Vaxart (VXRT) Current Deferred Revenue (2010 - 2026)
Vaxart's Current Deferred Revenue was $7.72 million in Q2 2026, down 96.1% from $196.18 million a year earlier and down 34.1% from the prior quarter.
Powered by 
Analysis
Vaxart (VXRT) Current Deferred Revenue (2010 - 2026) Analysis & Trends
At the end of FY2025, Current Deferred Revenue at Vaxart came in at $13 million, down 90.1% from FY2024.
- Current Deferred Revenue shows a three-year compound annual growth rate of 86.6% (FY2022 to FY2025).
- In earlier years, Current Deferred Revenue was $130.8 million in FY2024 and $2 million in FY2022.
- The Q2 2026 figure marks the lowest quarterly Current Deferred Revenue since Q3 2023.
- Compared with a year earlier, Current Deferred Revenue has declined for four straight quarters, with an average decline of 78.5% over the last four quarters.
- Per Business Quant data, VXRT's Current Deferred Revenue in the three quarters before Q2 2026 was $11.72 million (Q1 2026), $13 million (Q4 2025) and $129.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Vaxart | 115.76 Mn | 51.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.72 Mn |
| Mar 31, 2026 | 11.72 Mn |
| Dec 31, 2025 | 13.00 Mn |
| Sep 30, 2025 | 129.63 Mn |
| Jun 30, 2025 | 196.18 Mn |
| Mar 31, 2025 | 196.15 Mn |
| Dec 31, 2024 | 130.80 Mn |
| Sep 30, 2024 | 196.25 Mn |
| Sep 30, 2023 | 79,000.00 |
| Jun 30, 2023 | 300,000.00 |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 2.00 Mn |
| Sep 30, 2019 | 110,000.00 |
| Dec 31, 2018 | 3.33 Mn |
| Sep 30, 2018 | 3.28 Mn |
| Jun 30, 2018 | 3.15 Mn |
| Mar 31, 2018 | 2.04 Mn |
| Dec 31, 2017 | 1.20 Mn |
| Sep 30, 2017 | 1.50 Mn |
| Jun 30, 2017 | 1.40 Mn |
API Access
Vaxart Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VXRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "VXRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VXRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();